Page last updated: 2024-11-02

phenobarbital and Abruptio Placentae

phenobarbital has been researched along with Abruptio Placentae in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Abruptio Placentae: Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH.

Research Excerpts

ExcerptRelevanceReference
"The risks of preeclampsia (adjusted odds ratio [OR] 1."1.35Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes. ( Fraser, W; Olatunbosun, O; Walker, M; Wen, SW; Yang, Q; Zhou, J, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wen, SW1
Zhou, J1
Yang, Q1
Fraser, W1
Olatunbosun, O1
Walker, M1

Other Studies

1 other study available for phenobarbital and Abruptio Placentae

ArticleYear
Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Dec-02, Volume: 179, Issue:12

    Topics: Abruptio Placentae; Adult; Cohort Studies; Female; Fetal Death; Fetal Growth Retardation; Folic Acid

2008